No Data
No Data
PhoenixBio: Extraordinary Report
Phoenix Bio: confirmation letter
PhoenixBio: Financial Report - Term 23 (2023/04/01 - 2024/03/31)
Stocks with interesting flavors seen from changes in volume, such as REMIX.
Code Closing price Change Volume <3848>Data application 1000 98 199300 <4937>Waqoo 1795 27 63500 <6190>PXB 513 25 63300 <5035>Housei 499 21 188400 <2525>NZAM 225 40460 520 5131
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/15)
[Good news] ---- ---- ■ITbook Holdings [Tokyo Stock Exchange G] Current financial results increased 26% to the highest profit for 4 consecutive terms, to 6 yen this fiscal year. ■GNI Group [TSE G] landed in surplus at the end of the January-March period (1Q). Also, we will proceed with preparations for applying for a market classification change to the Tokyo Stock Exchange Prime Market. In addition, a joint venture for drug discovery and investment businesses utilizing AI technology will be established with Oltz and Governance Partners. ■Huh
PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.
No Data